Results 171 to 180 of about 3,721,297 (234)

Adaptogenic‐Like Potential of Bauhinia forficata Leaf Extracts: Behavioral and Oxidative Outcomes in an Acute Stress Mouse Model

open access: yesBrain and Behavior, Volume 16, Issue 10, October 2026.
Graphical abstract ilustrates the adaptogenic‐like potential of crude extracts (CEs) and dichloromethane (DCM) fraction from B. forficata leaves in an acute stress mouse model. C57BL/6J/UFU mice were submitted to a social isolation protocol and both CE (30 mg/kg) and DCM (10 mg/kg) significantly reduced immobility in the forced swim test and increased ...
Sofia Alencar Lafetá   +12 more
wiley   +1 more source

Diagnosis of an Arachnoid Cyst in a Patient Presenting With Uncommon Depressive Symptoms: Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Arachnoid cysts are most commonly asymptomatic and usually do not need any active treatment. Currently, psychiatric symptoms are seldom taken into consideration during treatment evaluations in this patient population. We present this case of a young man who was treated in our hospital for signs of depression.
Ruth Arias‐Hidalgo   +5 more
wiley   +1 more source

The Role of Glymphatic Clearance in Affective Decision‐Making in Adolescents with Non‐Suicidal Self‐Injury

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 10, October 2026.
In adolescents with non‐suicidal self‐injury (NSSI), characterized by sleep disturbances and metabolic burden, a disease‐specific, compensatory up‐regulation of glymphatic function (stronger gBOLD‐CSF coupling) selectively supports “hot” (affective) cognition while leaving “cold” (executive) cognition unlinked, functioning as a pathological buffer ...
Hongping Wang   +11 more
wiley   +1 more source

Agomelatine as augmentation therapy with second‐generation antipsychotics for negative symptoms of schizophrenia: An open‐label randomised clinical trial and electroencephalogram‐derived model for treatment response prediction

open access: yesGeneral Psychiatry, Volume 39, Issue 5, October 2026.
ABSTRACT Background Negative symptoms are a core diagnostic domain of schizophrenia that affect functional outcomes and remain difficult to treat. Agomelatine, a novel antidepressant with melatonin receptor agonism and serotonin 2C receptor antagonism, may have therapeutic potential.
Wanyan Zhou   +22 more
wiley   +1 more source

Hallucinogen-Psychosis Associations Are Confounded by Baseline Psychiatric History. [PDF]

open access: yesJ Clin Psychiatry
Steinle JT   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy